Onc.AI is a software that specializes in clinical oncology, genomics, proteomics, and radiomics.
Onc.AI has raised $2.0M in total funding. The most recent round was Grant. The last funding was announced in October 2024.
Onc.AI's investors include Digitalis Ventures, KdT Ventures, Life Extension Ventures, Accomplice, The Blue Venture Fund.
Onc.AI is headquartered in San Carlos, United States.
Onc.AI is a software that specializes in clinical oncology, genomics, proteomics, and radiomics.
Onc.AI is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Onc.AI — Funding & Investors." VCBacked, October 24, 2024, https://www.vcbacked.co/company/oncai. Accessed August 13, 2026.
VCBacked. (2024). Onc.AI — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/oncai
{{cite web |title=Onc.AI — Funding & Investors |url=https://www.vcbacked.co/company/oncai |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated